Results showed a trend towards improved long-term survival upon administering three vs. one treatment round of NSC.CRAd-S-pk7 ( Figure 3 A).
← all excerpts
Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of Glioblastoma.
1
—
—